Treatment of Patellofemoral Cartilage Defects in the Knee by Autologous Matrix-Induced Chondrogenesis (AMIC)


Published online: Jun 27 2014

Aad DHOLLANDER, Kris MOENS, Jaap VAN DER MAAS, Peter VERDONK, Karl Fredrik ALMQVIST, Jan VICTOR

From Ghent University Hospital, Ghent, Belgium

Abstract

This study presents the prospective two-year clinical and MRI outcome of autologous matrix-induced chondrogenesis (AMIC) for the treatment of patello-femoral cartilage defects in the knee. Ten patients were clinically prospectively evaluated during 2 years. MRI data were analysed based on the original and modified MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) scoring system. A satisfying clinical improvement became apparent during the 24 months of follow-up. The MOCART scoring system revealed a slight tendency to deterioration on MRI between one and 2 years of follow-up. However, the difference was not statistical significant. All cases showed subchondral lamina changes. The formation of intralesional osteophytes was observed in 3 of the 10 patients (30%). In conclusion, AMIC is safe and feasible for the treatment of symptomatic patellofemoral cartilage defects and resulted in a clinical improvement. However, the favourable clinical outcome of the AMIC technique was not confirmed by the MRI findings.